CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma

Establishing the diagnosis of focal brain lesions in patients with unexplained neurologic symptoms represents a challenge. The goal of this study is to provide evidence supporting functional roles for CXC chemokine ligand (CXCL)13 and interleukin (IL)-10 in central nervous system (CNS) lymphomas and...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Rubenstein, James L., Wong, Valerie S., Kadoch, Cigall, Gao, Hua-Xin, Barajas, Ramon, Chen, Lingjing, Josephson, S. Andrew, Scott, Brian, Douglas, Vanja, Maiti, Mekhala, Kaplan, Lawrence D., Treseler, Patrick A., Cha, Soonmee, Hwang, Jimmy H., Cinque, Paola, Cyster, Jason G., Lowell, Clifford
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Hematology 2013
Θέματα:
Lymphoid Neoplasia
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3674672/
https://ncbi.nlm.nih.gov/pubmed/23570798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-01-476333
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια